Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Morgan Stanley analyst says the recent drop in memory stocks is a healthy pullback. Memory supply remains the key constraint for AI growth, with strong cash flow expected to drive Micron and other stocks higher.
Kodiak Sciences shares surged after Zenkuda hit its primary endpoint in the GLOW2 Phase 3 study for diabetic retinopathy.
Wave Life Sciences' WVE-007 (INHBE-targeted) showed ~5% total fat reduction and 14% visceral fat drop with muscle preserved after one dose. Early results are modest (1% weight loss), but support infrequent dosing as potential GLP-1 complement.
Equitable and Corebridge will merge in a $22 billion all-stock deal to create a major retirement and life insurance company with $1.5 trillion in assets. The deal is expected to close by end of 2026.
Shareholders filed a lawsuit against Super Micro Computer, accusing the company of securities fraud by concealing risky sales to China that violated U.S. export laws.
Olaplex shares jumped 50% pre-market after Henkel agreed to buy the hair-care brand for $1.4 billion ($2.06/share, 55% premium). Deal closes H2 2026.
